Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer

  • Authors:
    • Yan-Wei Ye
    • Shuang Hu
    • Ying-Qiang Shi
    • Xie-Fu Zhang
    • Ye Zhou
    • Chun-Lin Zhao
    • Guo-Jun Wang
    • Jian-Guo Wen
    • Hong Zong
  • View Affiliations

  • Published online on: October 11, 2013     https://doi.org/10.3892/or.2013.2796
  • Pages: 2777-2784
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Our previous findings revealed that FGFR4 may be a novel therapeutic target for gastric cancer. The aim of the present study was to explore the effects of a combination of PD173074 (PD) and 5-fluorouracil (5-Fu) on the biological behavior of gastric cancer cell lines and the relevant mechanisms involved. MKN45, a gastric cancer cell line, was treated with each single agent alone or a combination of FGF19, PD and 5-Fu. Then, a series of functional assays were performed using CCK-8 assay and flow cytometry. Western blot analysis was used to determine the expression of signaling pathway and downstream-related molecules in the MKN45 cells following the different treatments. As the concentration of PD and 5-Fu increased, the cell viability gradually decreased; the viability of the combination group was less than the viability following single administration. Western blot analysis showed that FGFR4 expression was weak in the 5-Fu-treated groups when compared with the control. PD markedly increased the apoptosis rate of MKN45 cells when compared to the control; the apoptosis rate in the cells treated with the combination of PD and 5-Fu was higher than that in the cells following single treatment. Furthermore, PD reduced the expression of p-ERK and Bcl-xl and increased caspase-3 expression. Inhibition of the activity of FGFR4 may be the main mechanisms of PD effect while 5-Fu reduced FGFR4 expression. Furthermore, the effects of the combination of 5-Fu and PD in inhibiting proliferation, increasing apoptosis and arresting cell cycle were superior to these effects following the single agent treatments, suggesting that the two drugs applied in combination may contribute to the effective treatment of gastric cancer.
View Figures
View References

Related Articles

Journal Cover

December 2013
Volume 30 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ye Y, Hu S, Shi Y, Zhang X, Zhou Y, Zhao C, Wang G, Wen J and Zong H: Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer. Oncol Rep 30: 2777-2784, 2013
APA
Ye, Y., Hu, S., Shi, Y., Zhang, X., Zhou, Y., Zhao, C. ... Zong, H. (2013). Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer. Oncology Reports, 30, 2777-2784. https://doi.org/10.3892/or.2013.2796
MLA
Ye, Y., Hu, S., Shi, Y., Zhang, X., Zhou, Y., Zhao, C., Wang, G., Wen, J., Zong, H."Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer". Oncology Reports 30.6 (2013): 2777-2784.
Chicago
Ye, Y., Hu, S., Shi, Y., Zhang, X., Zhou, Y., Zhao, C., Wang, G., Wen, J., Zong, H."Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer". Oncology Reports 30, no. 6 (2013): 2777-2784. https://doi.org/10.3892/or.2013.2796